Avid Radiopharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVID RADIOPHARMS INC
AVID RADIOPHARMS INC has two approved drugs.
There are three US patents protecting AVID RADIOPHARMS INC drugs.
Summary for Avid Radiopharms Inc
| US Patents: | 3 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Avid Radiopharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-002 | May 28, 2020 | DISCN | Yes | No | 8,932,557 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-003 | Apr 6, 2012 | RX | Yes | Yes | 8,506,929 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-001 | Apr 6, 2012 | DISCN | Yes | No | 8,506,929 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-004 | Oct 13, 2023 | RX | Yes | Yes | 7,687,052 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-004 | Jul 1, 2022 | RX | Yes | Yes | 8,932,557 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Avid Radiopharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5290954 | ⤷ Start Trial |
| Hungary | E032660 | ⤷ Start Trial |
| Costa Rica | 10329 | ⤷ Start Trial |
| South Korea | 20080106564 | ⤷ Start Trial |
| Slovenia | 1999109 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Avid Radiopharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1999109 | 34/2013 | Austria | ⤷ Start Trial | PRODUCT NAME: FLORBETAPIR (18F); REGISTRATION NO/DATE: EU/1/12/805 20130114 |
| 1999109 | 1390030-3 | Sweden | ⤷ Start Trial | PRODUCT NAME: FLORBETAPIR (18F); REG. NO/DATE: EU/1/12/805 20130114 |
| 1999109 | 2013C/044 | Belgium | ⤷ Start Trial | PRODUCT NAME: AMYVID - FLORBETAPIR (18F); AUTHORISATION NUMBER AND DATE: EU/1/12/805 20130114 |
| 1999109 | CA 2013 00035 | Denmark | ⤷ Start Trial | |
| 1999109 | 92232 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: FLORBETAPIR (18 F) |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
